Below mentioned stocks have witnessed substantial growth in their share prices in the last three months. Further, these stock have made significant strategic advancements in the recent past. Let us take a closer at these stocks:
Resonance Health Limited (ASX: RHT)
Australian healthcare company, Resonance Health Limited (ASX: RHT) has entered into a Distribution Agreement with EnvoyAI Inc, a US Delaware Corporation, for the distribution of the Companyâs FerriSmartÂ® product, which recently received FDA regulatory clearance. Under the Distribution Agreement, EnvoyAI has the non-exclusive right for the marketing, promoting, and selling of FerriSmartÂ®, the Companyâs automated AI liver-iron-concentration quantification tool, through the EnvoyAI Platform.Â
Recently, the company executed a Non-exclusive License Agreement with the Wisconsin Alumni Research Foundation (WARF) for the use of numerous patents owned by WARF. Meanwhile, in the last three months, the share price of Resonance Health increased by 400.00 percent as on 15 January 2019 and is trading at a higher PE multiple of 183.330x. RHTâs shares traded at $0.100 with a market capitalization of circa $44.27 million as on 16 January 2019.
The A2 Milk Company Limited (ASX: A2M)
The A2 Milk Company Limited (ASX: A2M) witnessed strong growth in the first four months of FY 2019 with 40.5 percent growth in revenue, 58.5 percent in EBITDA, 60 percent growth in PBT and 64.5 percent growth in NPAT. The company infant formula witnessed strong sales across all stages of channels during FY 2018.
In FY 2019, the company is expecting its strong revenue growth to continue but at a slightly more moderate rate than in the first four months of FY 2019. The 2019 EBITDA to Sales ratio is expected to be broadly consistent with FY 2018 reflecting a higher gross margin percentage.
In FY 2018, the company earned a revenue of NZ$922.7 million which was 68 percent higher than the previous corresponding year.
Meanwhile, in the last three months, the share price of A2M increased by 26.24 percent as on 15 January 2019 and is trading at a PE multiple of 43.58x. A2Mâs shares traded at $11.420 (+1.873% intraday) with a market capitalization of circa $8.22 billion as on 16 January 2019.
Pursuit Minerals Ltd (ASX: PUR)
Mineral exploration and project development company, Pursuit Minerals Ltd (ASX: PUR) has confirmed the intersection of High-Grade Vanadium Mineralization in Southwest Magnetic Zone on the Airijoki Project. The mineralization was intercepted from the results of the four drill holes at the Airijoki Project. Recently, the company also intersected exceptional grade Vanadium concentrates at its Koitelainen Vosa Vanadium Prospect, following the results from 11 historical drill holes at the prospect. As at 30 September 2018, the company had a cash and cash equivalent of $457,000.Â In the past three months, the share price of the company increased by 20 percent but decreased by 14.29 percent in the past one month as on 15 January 2019. PURâs shares traded at $0.048 (-11.111% intraday) with a market capitalization of circa $7.71 million as on 16 January 2019.
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.